196 related articles for article (PubMed ID: 22125638)
21. Genome-wide association study of survival in patients with pancreatic adenocarcinoma.
Wu C; Kraft P; Stolzenberg-Solomon R; Steplowski E; Brotzman M; Xu M; Mudgal P; Amundadottir L; Arslan AA; Bueno-de-Mesquita HB; Gross M; Helzlsouer K; Jacobs EJ; Kooperberg C; Petersen GM; Zheng W; Albanes D; Boutron-Ruault MC; Buring JE; Canzian F; Cao G; Duell EJ; Elena JW; Gaziano JM; Giovannucci EL; Hallmans G; Hutchinson A; Hunter DJ; Jenab M; Jiang G; Khaw KT; LaCroix A; Li Z; Mendelsohn JB; Panico S; Patel AV; Qian ZR; Riboli E; Sesso H; Shen H; Shu XO; Tjonneland A; Tobias GS; Trichopoulos D; Virtamo J; Visvanathan K; Wactawski-Wende J; Wang C; Yu K; Zeleniuch-Jacquotte A; Chanock S; Hoover R; Hartge P; Fuchs CS; Lin D; Wolpin BM
Gut; 2014 Jan; 63(1):152-60. PubMed ID: 23180869
[TBL] [Abstract][Full Text] [Related]
22. Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients.
Rizzato C; Campa D; Talar-Wojnarowska R; Halloran C; Kupcinskas J; Butturini G; Mohelníková-Duchoňová B; Sperti C; Tjaden C; Ghaneh P; Hackert T; Funel N; Giese N; Tavano F; Pezzilli R; Pedata M; Pasquali C; Gazouli M; Mambrini A; Souček P; di Sebastiano P; Capurso G; Cantore M; Oliverius M; Offringa R; Małecka-Panas E; Strobel O; Scarpa A; Canzian F
Carcinogenesis; 2016 Oct; 37(10):957-64. PubMed ID: 27497070
[TBL] [Abstract][Full Text] [Related]
23. Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survival.
El Jellas K; Hoem D; Hagen KG; Kalvenes MB; Aziz S; Steine SJ; Immervoll H; Johansson S; Molven A
Cancer Med; 2017 Jul; 6(7):1531-1540. PubMed ID: 28556564
[TBL] [Abstract][Full Text] [Related]
24. Genetic variants in taste-related genes and risk of pancreatic cancer.
Gentiluomo M; Lu Y; Canzian F; Campa D
Mutagenesis; 2019 Dec; 34(5-6):391-394. PubMed ID: 31606007
[TBL] [Abstract][Full Text] [Related]
25. Re-evaluation of ABO gene polymorphisms detected in a genome-wide association study and risk of pancreatic ductal adenocarcinoma in a Chinese population.
Xu HL; Cheng JR; Zhang W; Wang J; Yu H; Ni QX; Risch HA; Gao YT
Chin J Cancer; 2014 Feb; 33(2):68-73. PubMed ID: 23816557
[TBL] [Abstract][Full Text] [Related]
26. Case-control study of diabetes-related genetic variants and pancreatic cancer risk in Japan.
Kuruma S; Egawa N; Kurata M; Honda G; Kamisawa T; Ueda J; Ishii H; Ueno M; Nakao H; Mori M; Matsuo K; Hosono S; Ohkawa S; Wakai K; Nakamura K; Tamakoshi A; Nojima M; Takahashi M; Shimada K; Nishiyama T; Kikuchi S; Lin Y
World J Gastroenterol; 2014 Dec; 20(46):17456-62. PubMed ID: 25516658
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide association study of pancreatic cancer in Japanese population.
Low SK; Kuchiba A; Zembutsu H; Saito A; Takahashi A; Kubo M; Daigo Y; Kamatani N; Chiku S; Totsuka H; Ohnami S; Hirose H; Shimada K; Okusaka T; Yoshida T; Nakamura Y; Sakamoto H
PLoS One; 2010 Jul; 5(7):e11824. PubMed ID: 20686608
[TBL] [Abstract][Full Text] [Related]
28. Genetic polymorphisms in inflammatory genes and pancreatic cancer risk: a two-phase study on more than 14 000 individuals.
Gentiluomo M; Peduzzi G; Lu Y; Campa D; Canzian F
Mutagenesis; 2019 Dec; 34(5-6):395-401. PubMed ID: 31748817
[TBL] [Abstract][Full Text] [Related]
29. Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer.
Walsh N; Zhang H; Hyland PL; Yang Q; Mocci E; Zhang M; Childs EJ; Collins I; Wang Z; Arslan AA; Beane-Freeman L; Bracci PM; Brennan P; Canzian F; Duell EJ; Gallinger S; Giles GG; Goggins M; Goodman GE; Goodman PJ; Hung RJ; Kooperberg C; Kurtz RC; Malats N; LeMarchand L; Neale RE; Olson SH; Scelo G; Shu XO; Van Den Eeden SK; Visvanathan K; White E; Zheng W; ; Albanes D; Andreotti G; Babic A; Bamlet WR; Berndt SI; Borgida A; Boutron-Ruault MC; Brais L; Brennan P; Bueno-de-Mesquita B; Buring J; Chaffee KG; Chanock S; Cleary S; Cotterchio M; Foretova L; Fuchs C; M Gaziano JM; Giovannucci E; Goggins M; Hackert T; Haiman C; Hartge P; Hasan M; Helzlsouer KJ; Herman J; Holcatova I; Holly EA; Hoover R; Hung RJ; Janout V; Klein EA; Kurtz RC; Laheru D; Lee IM; Lu L; Malats N; Mannisto S; Milne RL; Oberg AL; Orlow I; Patel AV; Peters U; Porta M; Real FX; Rothman N; Sesso HD; Severi G; Silverman D; Strobel O; Sund M; Thornquist MD; Tobias GS; Wactawski-Wende J; Wareham N; Weiderpass E; Wentzensen N; Wheeler W; Yu H; Zeleniuch-Jacquotte A; Kraft P; Li D; Jacobs EJ; Petersen GM; Wolpin BM; Risch HA; Amundadottir LT; Yu K; Klein AP; Stolzenberg-Solomon RZ
J Natl Cancer Inst; 2019 Jun; 111(6):557-567. PubMed ID: 30541042
[TBL] [Abstract][Full Text] [Related]
30. An evaluation study of reported pancreatic adenocarcinoma risk-associated SNPs from genome-wide association studies in Chinese population.
Wang X; Lin X; Na R; Jiang D; Zhang P; Li J; Jin C; Fu D; Xu J
Pancreatology; 2017; 17(6):931-935. PubMed ID: 28988600
[TBL] [Abstract][Full Text] [Related]
31. A resequence analysis of genomic loci on chromosomes 1q32.1, 5p15.33, and 13q22.1 associated with pancreatic cancer risk.
Parikh H; Jia J; Zhang X; Chung CC; Jacobs KB; Yeager M; Boland J; Hutchinson A; Burdett L; Hoskins J; Risch HA; Stolzenberg-Solomon RZ; Chanock SJ; Wolpin BM; Petersen GM; Fuchs CS; Hartge P; Amundadottir L
Pancreas; 2013 Mar; 42(2):209-15. PubMed ID: 23295781
[TBL] [Abstract][Full Text] [Related]
32. CD44 SNPrs187115: A Novel Biomarker Signature that Predicts Survival in Resectable Pancreatic Ductal Adenocarcinoma.
Stracquadanio G; Vrugt B; Flury R; Schraml P; Würl P; Müller TH; Knippschild U; Henne-Bruns D; Breitenstein S; Clavien PA; Graf R; Bond GL; Grochola LF
Clin Cancer Res; 2016 Dec; 22(24):6069-6077. PubMed ID: 27283965
[TBL] [Abstract][Full Text] [Related]
33. Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3.
Mocci E; Kundu P; Wheeler W; Arslan AA; Beane-Freeman LE; Bracci PM; Brennan P; Canzian F; Du M; Gallinger S; Giles GG; Goodman PJ; Kooperberg C; Le Marchand L; Neale RE; Shu XO; Visvanathan K; White E; Zheng W; Albanes D; Andreotti G; Babic A; Bamlet WR; Berndt SI; Blackford AL; Bueno-de-Mesquita B; Buring JE; Campa D; Chanock SJ; Childs EJ; Duell EJ; Fuchs CS; Gaziano JM; Giovannucci EL; Goggins MG; Hartge P; Hassan MM; Holly EA; Hoover RN; Hung RJ; Kurtz RC; Lee IM; Malats N; Milne RL; Ng K; Oberg AL; Panico S; Peters U; Porta M; Rabe KG; Riboli E; Rothman N; Scelo G; Sesso HD; Silverman DT; Stevens VL; Strobel O; Thompson IM; Tjonneland A; Trichopoulou A; Van Den Eeden SK; Wactawski-Wende J; Wentzensen N; Wilkens LR; Yu H; Yuan F; Zeleniuch-Jacquotte A; Amundadottir LT; Li D; Jacobs EJ; Petersen GM; Wolpin BM; Risch HA; Kraft P; Chatterjee N; Klein AP; Stolzenberg-Solomon R
Cancer Res; 2021 Jun; 81(11):3134-3143. PubMed ID: 33574088
[TBL] [Abstract][Full Text] [Related]
34. Impact of genetic variants of ABCB1, APOB, CAV1, and NAMPT on susceptibility to pancreatic ductal adenocarcinoma in Chinese patients.
Li B; Zhang C; Wang J; Zhang M; Liu C; Chen Z
Mol Genet Genomic Med; 2020 Jun; 8(6):e1226. PubMed ID: 32243098
[TBL] [Abstract][Full Text] [Related]
35. Germline genetic variability in pancreatic cancer risk and prognosis.
Gentiluomo M; Canzian F; Nicolini A; Gemignani F; Landi S; Campa D
Semin Cancer Biol; 2022 Feb; 79():105-131. PubMed ID: 32818625
[TBL] [Abstract][Full Text] [Related]
36. Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk.
Ünal P; Lu Y; Bueno-de-Mesquita B; van Eijck CHJ; Talar-Wojnarowska R; Szentesi A; Gazouli M; Kreivenaite E; Tavano F; Małecka-Wojciesko E; Erőss B; Oliverius M; Bunduc S; Nóbrega Aoki M; Vodickova L; Boggi U; Giaccherini M; Kondrackiene J; Chammas R; Palmieri O; Theodoropoulos GE; Bijlsma MF; Basso D; Mohelnikova-Duchonova B; Soucek P; Izbicki JR; Kiudelis V; Vanella G; Arcidiacono PG; Włodarczyk B; Hackert T; Schöttker B; Uzunoglu FG; Bambi F; Goetz M; Hlavac V; Brenner H; Perri F; Carrara S; Landi S; Hegyi P; Dijk F; Maiello E; Capretti G; Testoni SGG; Petrone MC; Stocker H; Ermini S; Archibugi L; Gentiluomo M; Cavestro GM; Pezzilli R; Di Franco G; Milanetto AC; Sperti C; Neoptolemos JP; Morelli L; Vokacova K; Pasquali C; Lawlor RT; Bazzocchi F; Kupcinskas J; Capurso G; Campa D; Canzian F
Hum Genomics; 2024 Feb; 18(1):12. PubMed ID: 38308339
[TBL] [Abstract][Full Text] [Related]
37. Association of breast cancer susceptibility variants with risk of pancreatic cancer.
Couch FJ; Wang X; McWilliams RR; Bamlet WR; de Andrade M; Petersen GM
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3044-8. PubMed ID: 19843670
[TBL] [Abstract][Full Text] [Related]
38. Relationship between pancreatic intraepithelial neoplasias, pancreatic ductal adenocarcinomas, and single nucleotide polymorphisms in autopsied elderly patients.
Matsuda Y; Tanaka M; Sawabe M; Mori S; Muramatsu M; Mieno MN; Furukawa T; Arai T
Genes Chromosomes Cancer; 2018 Jan; 57(1):12-18. PubMed ID: 28639428
[TBL] [Abstract][Full Text] [Related]
39. Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data.
Pierce BL; Austin MA; Ahsan H
Cancer Causes Control; 2011 Jun; 22(6):877-83. PubMed ID: 21445555
[TBL] [Abstract][Full Text] [Related]
40. Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer.
Schirmer MA; Lüske CM; Roppel S; Schaudinn A; Zimmer C; Pflüger R; Haubrock M; Rapp J; Güngör C; Bockhorn M; Hackert T; Hank T; Strobel O; Werner J; Izbicki JR; Johnsen SA; Gaedcke J; Brockmöller J; Ghadimi BM
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26857392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
